(Q35207551)

7 August 2017

1 reference

title

Pharmacogenetics of monoamine transporters (English)

1 reference

7 August 2017

Victor I Reus

2

0 references

author name string

Charles E Glatt

series ordinal

1

1 reference

7 August 2017

publication date

1 September 2003

1 reference

7 August 2017

1 reference

7 August 2017

volume

4

1 reference

7 August 2017

issue

5

1 reference

7 August 2017

page(s)

583-596

1 reference

Pharmacological profile of antidepressants and related compounds at human monoamine transporters

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Neurotransmitter transporters: fruitful targets for CNS drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Genetic mechanisms for variability in drug response and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Partitioning of genetic variation between regulatory and coding gene segments: the predominance of software variation in genes encoding introvert proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Binding of antidepressants to human brain receptors: focus on newer generation compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Amitriptyline. A review of its pharmacological properties and therapeutic use in chronic pain states

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Antidepressants for chronic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Antidepressants in the treatment of migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Treatment of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Obsessive-complusive disorder: pharmacological treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Paroxetine: an update of its use in psychiatric disorders in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Efficacy and tolerability of reboxetine compared with imipramine in a double-blind study in patients suffering from major depressive offsodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

The dopamine hypothesis of the reinforcing properties of cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Cocaine self-administration in dopamine-transporter knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Mice lacking the norepinephrine transporter are supersensitive to psychostimulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Systematic search for variation in the human norepinephrine transporter gene: identification of five naturally occurring missense mutations and study of association with major psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Natural variation in human membrane transporter genes reveals evolutionary and functional constraints

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Characterization of single-nucleotide polymorphisms in coding regions of human genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Screening a large reference sample to identify very low frequency sequence variants: comparisons between two genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

The future of genetic studies of complex human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Searching for genetic determinants in the new millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Allelic Variation of Human Serotonin Transporter Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

A novel allele in the promoter region of the human serotonin transporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Polymorphisms in the 3'-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

No association between the serotonergic polymorphisms and incidence of nausea induced by fluvoxamine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Association of the dopamine transporter gene (DAT1) with poor methylphenidate response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Marker gene polymorphisms in hyperkinetic disorder--predictors of clinical response to treatment with methylphenidate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

21 January 2018

Dopamine genes and ADHD.

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

L -dopa-induced adverse effects in PD and dopamine transporter gene polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Identification of a Coordinate Regulator of Interleukins 4, 13, and 5 by Cross-Species Sequence Comparisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

The human phenome project

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

A novel allelic variant of the human serotonin transporter gene regulatory polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Allelic Variation in Human Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Efficacy of Paroxetine in Depression Is Influenced by a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Ethnicity and treatment response in schizophrenia: a comparison of 3 ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Effects of dextroamphetamine on depression and fatigue in men with HIV: a double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Organization of the human serotonin transporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

VNTR polymorphism for the human dopamine transporter gene (DAT1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Serotonin transporter gene polymorphism and antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

Serotonin transporter (5-HTT) gene polymorphisms and susceptibility to cocaine dependence among African-American individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.5.583.23789

10.1517/PHGS.4.5.583.23789

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference